| Literature DB >> 7392529 |
M Bulla, G Delling, G Benz-Bohm, G J Stock, A Sánchez de Reutter, R Ziegler, H Lühmann, M Severin, E Kalbitzer, C Manegold.
Abstract
Growth arrest and renal osteodystrophy are major problems in renal insufficiency of children. The present report describes our experiences in managing renal osteodystrophy in 14 dialyzed children using 1,25-DHCC for 12 months. Values in plasma of Ca, P, Mg, alkaline phosphatase, iPTH, 25-OH-D, and 1,25-DHCC were determined regulary. Skeletal X-rays and analysis of iliac crest biopsies were obtained in each child. In treatment with 1,25-DHCC episodes of severe but reversible hypercalcemia occurred. Alkaline phosphatase and iPTH normalized completely. Radiographic examinations revealed marked improvement. Histological signs of fibro-osteoclasia and resorptive defects disappeared but there was no recovery of osteomalacia. A reduction of osteoblast population and of bone transformation was obvious. 1,25-DHCC failed to normalize growth in uremic children. In short, neither vitamin D nor 1,25-DHCC can guarantee complete recovery of renal osteodystrophy and growth arrest in uremic children.Entities:
Mesh:
Substances:
Year: 1980 PMID: 7392529 DOI: 10.1007/bf01477068
Source DB: PubMed Journal: Klin Wochenschr ISSN: 0023-2173